The Ethics of Innovation: Disability, Technology, and Reproductive Justice – with Katie Hasson
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson],
Disability Deep Dive
| 07. 24. 2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into the ethical concerns surrounding genetic technologies, the medical vs. social model of disability, and the risk of eugenics in current bioethical practices. Katie also highlights the Center's work in ensuring social justice and equity in biotechnologies, and emphasizing the importance of including disabled voices in policy discussions. The episode concludes with a discussion on the documentary 'Fixed: The Science/Fiction of Human Enhancement,' which examines the impact of biotechnology on the disabled community.
Episode Transcript
Jodi Beckstine (00:01):
Want to talk and explore how disability science and ethics collide in today's tech-driven world? We're diving headfirst into the ethics of innovation on this episode of Disability Deep Dive.
Keith Casebonne (00:38):
Hello, listeners. We are really glad you're here. I'm Keith.
Jodi Beckstine (00:41):
And I'm Jody. Welcome back to Disability Deep Dive.
Keith Casebonne (00:45):
Today's episode is called the...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...